The study, published in JAMA Network Open, is based on data from nearly 8,000 breast cancer patients between 2006 and 2023, according to HealthDay.
Researchers compared patients using GLP-1 drugs with patients treated with other types of diabetes medication, including insulin and metformin.
Lower risk of death
According to the study, patients using GLP-1 medication had a lower risk of death over the following ten years.
The data also showed that the cancer was less likely to return after treatment.
Also read: Gastroenterologist explains why eating fruit right after dinner may be a bad idea
Researchers do not yet know exactly why the drugs appear to have a positive effect on the body.
Possible explanations include weight loss, improved cardiovascular health, and other biological factors.
More answers still needed
Researchers are now planning new clinical trials to investigate the connection further.
These types of trials are used to determine whether the medication directly affects the disease.
Also read: This can happen to your sleep if you combine magnesium and melatonin
GLP-1 drugs may potentially improve both survival rates and reduce the risk of recurrence in some breast cancer patients.
However, the researchers stress that the findings have not yet been conclusively proven and that more research is needed.
Sources: HealthDay and JAMA Network Open.
Also read: Senator Chuck Schumer after Trump’s posts: “He is unwell”